Literature DB >> 8677660

[Intraventricular morphine administration as a treatment possibility for patients with intractable pain].

M Seiwald1, F Alesch, A Kofler.   

Abstract

The treatment of intractable pain, especially in cancer patients, often sets problems to patient and therapist. While epidural and intrathecal spinal administration of opiates is a routine treatment in pain with a sub-diaphragmatic topography it is almost ineffective in cervicocephalic or thoracic cancer. An alternative here is the administration of morphine into the lateral or third ventricle by a catheter-reservoir system. We report on our experience in the treatment of twenty patients, mostly suffering from cancer (18 cases), from 1990 to 1993. It is shown to be an effective, non-destructive method with minimal side effects in the treatment of nociceptive pain. Analgesia takes effect within a few minutes and the necessary doses are low. Our results agree with those of other authors describing good to excellent results in 95% of patients with somatogenic pain. However, no or only minimal effect is achieved in the treatment of neurogenic pain by intracerebroventricular morphine therapy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8677660

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  4 in total

1.  The in vitro pharmacological profile of TD-1211, a neutral opioid receptor antagonist.

Authors:  Pamela R Tsuruda; Ross G Vickery; Daniel D Long; Scott R Armstrong; David T Beattie
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-04-04       Impact factor: 3.000

Review 2.  Intracerebroventricular opioids for intractable pain.

Authors:  Robert B Raffa; Joseph V Pergolizzi
Journal:  Br J Clin Pharmacol       Date:  2012-07       Impact factor: 4.335

3.  Preoperative oral administration of fast-release morphine sulfate reduces postoperative piritramide consumption.

Authors:  Ana Reiter; Ernest Zulus; Thomas Hartmann; Klaus Hoerauf
Journal:  Wien Klin Wochenschr       Date:  2003-07-15       Impact factor: 1.704

4.  Intrathecal Pump Implantation in the Cisterna Magna for Treating Intractable Cancer Pain.

Authors:  Yaling Lou; Yuefeng Rao; Zhiying Feng
Journal:  Case Rep Anesthesiol       Date:  2018-09-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.